MDA and MDMA are related substances within the amphetamine class, sharing a similar chemical foundation but with distinct effects. Also known by their street names “Molly” and “Sally,” MDMA and MDA ...

A novel, non-hallucinogenic, experimental drug shows statistically significant, rapid, and durable improvement in PTSD symptom severity in a phase 2 trial.

An F.D.A. advisory panel dealt a setback to those seeking treatment for PTSD, citing health risks of the illegal drug and study flaws. By Andrew Jacobs The Food and Drug Administration is weighing ...

Also known as molly or ecstasy, MDMA has the potential to treat post-traumatic stress disorder (PTSD). But psychedelic-assisted therapy can only be administered by a trained professional. Without the ...

The agency’s staff analysis suggests that approval of the illegal drug known as Ecstasy for treatment of PTSD is far from certain, with advisers meeting next week to consider the proposed therapy. By ...

As psychedelic-assisted therapy grows in popularity, several substances are being recognized for their potential in treating trauma. Psilocybin, ketamine, and MDMA have emerged as some of the most ...

The high incidence of acute hyponatremia after the administration of a single dose of 3,4-methylenedioxymethamphetamine (MDMA), also known as ecstasy, in healthy individuals may be mediated by ...

MDMA (3,4-methylenedioxymethamphetamine), known colloquially as Molly and Ecstasy, is a synthetic drug with effects similar to stimulants like methamphetamine. It was first synthesized in 1912 by ...

When the Food and Drug Administration (FDA) declined to approve MDMA-assisted psychotherapy as a treatment for post-traumatic stress disorder (PTSD) last year, the details of its objections were not ...

Many people have interpreted as a setback the “no” vote by an advisory committee to the Food and Drug Administration on Lykos Therapeutics’ new drug application for MDMA-assisted psychotherapy for ...